Gauthey Anaïs, Calle Simon, Accinelli Stefano, Depuydt Philippe, Garnir Quentin, Scavée Christophe, Marchandise Sébastien, Wauters Aurélien, Bordachar Pierre, de Pooter Jan, le Polain de Waroux Jean-Benoît
Division of Cardiology, Cliniques Universitaires St-Luc, Université Catholique de Louvain, Brussels, Belgium.
Heart Center, Gent University Hospital, Ghent, Belgium.
J Cardiovasc Electrophysiol. 2020 Jul;31(7):1793-1800. doi: 10.1111/jce.14566. Epub 2020 May 29.
Management of subcutaneous implantable cardioverter defibrillator (S-ICD) patients with newly acquired pacing needs remains problematic. His bundle pacing (HBP) allows for cardiac pacing without significant changes in the QRS morphology. We hypothesized that HBP does not alter S-ICD sensing and functions.
Twenty consecutive patients were implanted with a HB pacemaker. Among them, 17 demonstrated successful His recruitment and were prospectively screened with the automated screening tool (AST). Results of screenings performed immediately after implant and during follow-up, during intrinsic rhythm and while pacing from all available pacing configurations, were compared using the AST score. Positive-screening tests were defined by greater than or equal to 1 positive vector.
Among the 17 patients successfully implanted (male: 41%; mean age: 73), 13 presented an indication of ventricular pacing and four of cardiac resynchronization. Absolute AST scores during both HBP (all configurations) and intrinsic rhythm were similar (p: NS). Due to left bundle branch block correction, HBP resulted in higher number of positive vectors (AST ≥ 100). AST scores were higher during HBP when compared with right ventricular pacing (RVP) (primary vector: 272 [16; 648] vs 4.6 [0.8; 16.2]; P = .003; secondary vector: 569 [183; 1186] vs 1.5 [0.7; 8.3]; P < .0001; alternate vector: 44 [2;125] vs 4.8 [0.9; 9.3]; P = .02) and resulted in a much higher number of positive vectors. Up to 90% of the patients had a positive-screening test during HBP. This passing rate was higher when compared RVP (17%; P < .0001).
HBP restores normal intrinsic conduction and minimally modifies the surface electrocardiograph and subcutaneous electrograms. When ventricular pacing is needed, HBP might represent an ideal pacing option for patients implanted with a S-ICD.
对于有新出现起搏需求的皮下植入式心律转复除颤器(S-ICD)患者,其管理仍存在问题。希氏束起搏(HBP)可实现心脏起搏,且QRS形态无显著变化。我们推测HBP不会改变S-ICD的感知和功能。
连续20例患者植入了希氏束起搏器。其中,17例成功实现希氏束夺获,并使用自动筛查工具(AST)进行前瞻性筛查。比较植入后即刻、随访期间、固有心律时以及从所有可用起搏配置进行起搏时使用AST评分进行的筛查结果。阳性筛查试验定义为大于或等于1个阳性向量。
在成功植入的17例患者中(男性:41%;平均年龄:73岁),13例有心室起搏指征,4例有心脏再同步化指征。HBP(所有配置)期间和固有心律时的绝对AST评分相似(p:无显著性差异)。由于左束支传导阻滞得到纠正,HBP导致阳性向量数量增加(AST≥100)。与右心室起搏(RVP)相比,HBP期间的AST评分更高(主要向量:272 [16;648] 对4.6 [0.8;16.2];P = 0.003;次要向量:569 [183;1186] 对1.5 [0.7;8.3];P < 0.0001;交替向量:44 [2;125] 对4.8 [0.9;9.3];P = 0.02),并导致阳性向量数量多得多。高达90%的患者在HBP期间有阳性筛查试验。与RVP相比,该通过率更高(17%;P < 0.0001)。
HBP可恢复正常的固有传导,并对体表心电图和皮下电图的改变最小。当需要心室起搏时,HBP可能是植入S-ICD患者的理想起搏选择。